(Press-News.org) Illnesses caused by many of the world's most deadly viruses cannot be effectively treated with existing drugs or vaccines. A study published by Cell Press in the March 21 issue of the journal Chemistry & Biology has revealed several compounds that can inhibit multiple viruses, such as highly lethal Ebola virus, as well as pathogens responsible for rabies, mumps, and measles, opening up new therapeutic avenues for combating highly pathogenic viruses.
"The medical field currently does not have ideal antiviral therapies, often no therapeutics at all, and the development of broad-spectrum antivirals is a great way to provide treatment in the future," says study author Claire Marie Filone of Boston University School of Medicine. "Toward that end, we have identified a drug that targets multiple viruses- and may be developed into an antiviral treatment for known and emerging viruses."
Many viruses that cause human diseases are nonsegmented, negative-strand (NNS) RNA viruses, which include the highly lethal Ebola virus and other pathogens mentioned above. In contrast to the many antibiotics that work against a wide range of bacteria, there are currently no highly effective or safe broad-spectrum drug treatments for viral diseases.
To address this need, John Connor and John Snyder of Boston University and their team screened thousands of diverse compounds for small molecules that showed strong antiviral activity against multiple NNS viruses. They identified several molecules that inhibited infection in cells exposed to either Ebola or another NNS virus called vesicular stomatitis virus. These molecules, which are related to a class of plant-derived compounds called indoline alkaloids, share a common chemical structure that can be modified to enhance antiviral activity.
The most potent of these compounds turned off NNS viral genes by blocking transcription. "Because our antiviral targets such a critical step in virus replication, we may be able to develop it into a therapeutic that could be used against many different types of viral infections," Filone says.
INFORMATION:
Chemistry & Biology, Filone et al.: "Identification of a broad-spectrum inhibitor of virus RNA synthesis: validation of a prototype virus-based approach."
Study reveals potential treatments for Ebola and a range of other deadly viruses
2013-03-21
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Harnessing immune cells' adaptability to design an effective HIV vaccine
2013-03-21
In infected individuals, HIV mutates rapidly to escape recognition by immune cells. This process of continuous evolution is the main obstacle to natural immunity and the development of an effective vaccine. A new study published by Cell Press in the March 21 issue of the journal Immunity reveals that the immune system has the capacity to adapt such that it can recognize mutations in HIV. The findings suggest that our immune cells' adaptability could be harnessed to help in the fight against AIDS.
An international collaboration between research groups in France, England, ...
Functional characteristics of antitumor T cells change w increasing time after therapeutic transfer
2013-03-21
PHILADELPHIA — Scientists have characterized how the functionality of genetically engineered T cells administered therapeutically to patients with melanoma changed over time. The data, which are published in Cancer Discovery, a journal of the American Association for Cancer Research, highlight the need for new strategies to sustain antitumor T cell functionality to increase the effectiveness of this immunotherapeutic approach.
Early clinical research has indicated that cell-based immunotherapies for cancer, in particular melanoma, have potential because patients treated ...
Adults worldwide eat almost double daily AHA recommended amount of sodium
2013-03-21
Seventy-five percent of the world's population consumes nearly twice the daily recommended amount of sodium (salt), according to research presented at the American Heart Association's Nutrition, Physical Activity and Metabolism and Cardiovascular Disease Epidemiology and Prevention 2013 Scientific Sessions.
Global sodium intake from commercially prepared food, table salt, salt and soy sauce added during cooking averaged nearly 4,000 mg a day in 2010.
The World Health Organization recommends limiting sodium to less than 2,000 mg a day and the American Heart Association ...
Japanese researchers identify a protein linked to the exacerbation of COPD
2013-03-21
Researchers from the RIKEN Advanced Science Institute and Nippon Medical School in Japan have identified a protein likely to be involved in the exacerbation of chronic obstructive pulmonary disease (COPD). This protein, Siglec-14, could serve as a potential new target for the treatment of COPD exacerbation.
In a study published today in the journal Cellular and Molecular Life Sciences the researchers show that COPD patients who do not express Siglec-14, a glycan-recognition protein, are less susceptible to exacerbation compared with those who do.
COPD is a chronic ...
Scripps Research study underlines potential of new technology to diagnose disease
2013-03-21
JUPITER, FL – March 21, 2013 – Researchers at The Scripps Research Institute (TSRI) in Jupiter, FL, have developed cutting-edge technology that can successfully screen human blood for disease markers. This tool may hold the key to better diagnosing and understanding today's most pressing and puzzling health conditions, including autoimmune diseases.
"This study validates that the 'antigen surrogate' technology will indeed be a powerful tool for diagnostics," said Thomas Kodadek, PhD, a professor in the Departments of Chemistry and Cancer Biology and vice chairman of ...
BUSM researchers identify chemical compounds that halt virus replication
2013-03-21
(Boston) – Researchers at Boston University School of Medicine (BUSM) have identified a new chemical class of compounds that have the potential to block genetically diverse viruses from replicating. The findings, published in Chemistry & Biology, could allow for the development of broad-spectrum antiviral medications to treat a number of viruses, including the highly pathogenic Ebola and Marburg viruses.
Claire Marie Filone, PhD, postdoctoral researcher at BUSM and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), is the paper's first ...
ACMG releases report on incidental findings in clinical exome and genome sequencing
2013-03-21
The American College of Medical Genetics and Genomics (ACMG) released the widely-anticipated "ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing" report at its 2013 Annual Clinical Genetics Meeting today in Phoenix. The ACMG Annual Clinical Genetics Meeting is one of the largest gatherings of medical and health professionals in genetics in the world.
As exome and genome sequencing become more commonly used in medical care, doctors will increasingly be able to learn about genetic changes that increase an individual's risk ...
Can we treat a 'new' coronary heart disease risk factor?
2013-03-21
NEW YORK – Depressive symptoms after heart disease are associated with a markedly increased risk of death or another heart attack. However, less has been known about whether treating heart attack survivors for depressive symptoms could relieve these symptoms, be cost-effective, and ultimately, reduce medical risk? Columbia University Medical Center's Karina W. Davidson, PhD and her research team now report a patient-centered approach that answers these questions in the affirmative.
With a grant from the National Institutes of Health's National Heart, Lung, and Blood Institute ...
Exploring the link between traumatic brain injury and people who are homeless
2013-03-21
TORONTO, March 21, 2013—Homeless people and their health care providers need to know more about traumatic brain injuries to help prevent and treat such injuries, a new study has found.
Homeless people have a disproportionately higher risk for TBI compared to the general population, yet little is known about the severity of those injuries, who exactly is suffering from them and what the long-term consequences are.
"A better understanding of TBI, its presentation and characteristics in the homeless is vital in order to enable appropriate interventions, treatments, and ...
Dysfunction in cerebellar Calcium channel causes motor disorders and epilepsy
2013-03-21
A dysfunction of a certain Calcium channel, the so called P/Q-type channel, in neurons of the cerebellum is sufficient to cause different motor diseases as well as a special type of epilepsy. This is reported by the research team of Dr. Melanie Mark and Prof. Dr. Stefan Herlitze from the Ruhr-Universität Bochum. They investigated mice that lacked the ion channel of the P/Q-type in the modulatory input neurons of the cerebellum. "We expect that our results will contribute to the development of treatments for in particular children and young adults suffering from absence ...